210 related articles for article (PubMed ID: 16361267)
1. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic dihydrobenzoxazepine and tetracyclic indole derivatives can specifically target bacterial DNA ligases and can distinguish them from human DNA ligase I.
Yadav N; Khanam T; Shukla A; Rai N; Hajela K; Ramachandran R
Org Biomol Chem; 2015 May; 13(19):5475-87. PubMed ID: 25875403
[TBL] [Abstract][Full Text] [Related]
3. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
[TBL] [Abstract][Full Text] [Related]
4. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
Singh V; Somvanshi P
Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibiotics.
Korycka-Machala M; Rychta E; Brzostek A; Sayer HR; Rumijowska-Galewicz A; Bowater RP; Dziadek J
Antimicrob Agents Chemother; 2007 Aug; 51(8):2888-97. PubMed ID: 17548501
[TBL] [Abstract][Full Text] [Related]
6. Structure based identification of first-in-class fragment inhibitors that target the NMN pocket of M. tuberculosis NAD
Shukla A; Afsar M; Kumar N; Kumar S; Ramachandran R
J Struct Biol; 2021 Mar; 213(1):107655. PubMed ID: 33197566
[TBL] [Abstract][Full Text] [Related]
7. NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis. Crystal structure of the adenylation domain and identification of novel inhibitors.
Srivastava SK; Tripathi RP; Ramachandran R
J Biol Chem; 2005 Aug; 280(34):30273-81. PubMed ID: 15901723
[TBL] [Abstract][Full Text] [Related]
8. Naphthalimides Selectively Inhibit the Activity of Bacterial, Replicative DNA Ligases and Display Bactericidal Effects against Tubercle Bacilli.
Korycka-Machala M; Nowosielski M; Kuron A; Rykowski S; Olejniczak A; Hoffmann M; Dziadek J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106753
[TBL] [Abstract][Full Text] [Related]
9. NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor.
Dwivedi N; Dube D; Pandey J; Singh B; Kukshal V; Ramachandran R; Tripathi RP
Med Res Rev; 2008 Jul; 28(4):545-68. PubMed ID: 18080330
[TBL] [Abstract][Full Text] [Related]
10. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.
Bi F; Ma R; Ma S
Curr Pharm Des; 2017; 23(14):2117-2130. PubMed ID: 27784238
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and genetic analysis of the four DNA ligases of mycobacteria.
Gong C; Martins A; Bongiorno P; Glickman M; Shuman S
J Biol Chem; 2004 May; 279(20):20594-606. PubMed ID: 14985346
[TBL] [Abstract][Full Text] [Related]
13. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
Murphy-Benenato K; Wang H; McGuire HM; Davis HE; Gao N; Prince DB; Jahic H; Stokes SS; Boriack-Sjodin PA
Bioorg Med Chem Lett; 2014 Jan; 24(1):360-6. PubMed ID: 24287382
[TBL] [Abstract][Full Text] [Related]
14. M. tuberculosis class II apurinic/ apyrimidinic-endonuclease/3'-5' exonuclease (XthA) engages with NAD+-dependent DNA ligase A (LigA) to counter futile cleavage and ligation cycles in base excision repair.
Khanam T; Afsar M; Shukla A; Alam F; Kumar S; Soyar H; Dolma K; Pasupuleti M; Srivastava KK; Ampapathi RS; Ramachandran R
Nucleic Acids Res; 2020 May; 48(8):4325-4343. PubMed ID: 32232338
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Inhibitors of
Alomari A; Gowland R; Southwood C; Barrow J; Bentley Z; Calvin-Nelson J; Kaminski A; LeFevre M; Callaghan AJ; Vincent HA; Gowers DM
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923034
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling of NAD+-dependent DNA ligase of the Wolbachia endosymbiont of Brugia malayi and its drug target potential using dispiro-cycloalkanones.
Shrivastava N; Nag JK; Pandey J; Tripathi RP; Shah P; Siddiqi MI; Misra-Bhattacharya S
Antimicrob Agents Chemother; 2015 Jul; 59(7):3736-47. PubMed ID: 25845868
[TBL] [Abstract][Full Text] [Related]
18. Analysis of ligation and DNA binding by Escherichia coli DNA ligase (LigA).
Wilkinson A; Smith A; Bullard D; Lavesa-Curto M; Sayer H; Bonner A; Hemmings A; Bowater R
Biochim Biophys Acta; 2005 May; 1749(1):113-22. PubMed ID: 15848142
[TBL] [Abstract][Full Text] [Related]
19. Specific and potent inhibition of NAD+-dependent DNA ligase by pyridochromanones.
Brötz-Oesterhelt H; Knezevic I; Bartel S; Lampe T; Warnecke-Eberz U; Ziegelbauer K; Häbich D; Labischinski H
J Biol Chem; 2003 Oct; 278(41):39435-42. PubMed ID: 12867414
[TBL] [Abstract][Full Text] [Related]
20. NAD+-dependent DNA ligases of Mycobacterium tuberculosis and Streptomyces coelicolor.
Wilkinson A; Sayer H; Bullard D; Smith A; Day J; Kieser T; Bowater R
Proteins; 2003 May; 51(3):321-6. PubMed ID: 12696044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
